All translations
Jump to navigation
Jump to search
Enter a message name below to show all available translations.
Found 2 translations.
| Name | Current message text |
|---|---|
| h English (en) | ! Defect ! Increased lipoprotein ! Main symptoms ! Treatment ! Serum appearance ! Estimated prevalence |- !rowspan=3| [[Type I hyperlipoproteinemia|Type I]] ! [[Hyperlipoproteinemia type Ia|a]] | {{OMIM|238600||none}} | Buerger-Gruetz syndrome or familial hyperchylomicronemia | Decreased [[lipoprotein lipase]] (LPL) |rowspan=3| [[Chylomicrons]] |rowspan=3| [[Acute pancreatitis]], [[lipemia retinalis]], eruptive skin [[xanthoma]]s, [[hepatosplenomegaly]] |rowspan=3| Diet control |rowspan=3| Creamy top layer |rowspan=3| One in 1,000,000 |- ! [[hyperlipoproteinemia type Ib|b]] | {{OMIM|207750||none}} | Familial apoprotein CII deficiency | Altered [[apolipoprotein C2|ApoC2]] |- ! [[Hyperlipoproteinemia type Ic|c]] | {{OMIM|118830||none}} | | [[Lipoprotein lipase|LPL]] inhibitor in blood |- !rowspan=2| Type II ! a | {{OMIM|143890||none}} | [[Familial hypercholesterolemia]] | [[LDL receptor]] deficiency | [[LDL]] | [[Xanthelasma]], [[arcus senilis]], tendon xanthomas | [[Bile acid sequestrant]]s, [[statin]]s, [[niacin (substance)|niacin]] | Clear | One in 500 for heterozygotes |- ! b | {{OMIM|144250||none}} | Familial combined hyperlipidemia | Decreased [[LDL receptor]] and increased [[apolipoprotein B|ApoB]] | [[LDL]] and [[VLDL]] | | Statins, niacin, [[fibrate]] | Turbid | One in 100 |- !colspan=2| Type III | {{OMIM|107741||none}} | [[Familial dysbetalipoproteinemia]] | Defect in [[apolipoprotein E|Apo E 2]] synthesis | [[Intermediate density lipoprotein|IDL]] | Tuberoeruptive xanthomas and palmar xanthomas | Fibrate, statins | Turbid | One in 10,000 |- !colspan=2| Type IV | {{OMIM|144600||none}} | [[Familial hypertriglyceridemia]] | Increased VLDL production and decreased elimination | VLDL |Can cause [[pancreatitis]] at high triglyceride levels | Fibrate, niacin, statins | Turbid | One in 100 |- !colspan=2| [[#type V|Type V]] | {{OMIM|144650||none}} | | Increased VLDL production and decreased [[Lipoprotein lipase|LPL]] | VLDL and chylomicrons | | Niacin, fibrate | Creamy top layer and turbid bottom | |} |
| h Japanese (ja) | ! 欠陥 ! リポ蛋白質の増加 ! 主な症状 ! 治療 ! 血清の外観 ! 推定有病率 |- !rowspan=3| [[Type I hyperlipoproteinemia/ja|I型]] ! [[Hyperlipoproteinemia type Ia/ja|a]] | {{OMIM|238600||none}} | Buerger-Gruetz症候群または家族性高カイロミクロン血症 | [[lipoprotein lipase/ja]]の減少 (LPL) |rowspan=3| [[Chylomicrons/ja]] |rowspan=3| [[Acute pancreatitis/ja]], [[lipemia retinalis/ja]], 発疹性皮膚[[xanthoma/ja|黄色腫]]症, [[hepatosplenomegaly/ja]] |rowspan=3| 食事管理 |rowspan=3| クリーミーなトップ層 |rowspan=3| 100万分の1 |- ! [[hyperlipoproteinemia type Ib/ja|b]] | {{OMIM|207750||none}} | 家族性アポ蛋白CII欠損症 | 変化した[[apolipoprotein C2/ja|ApoC2]] |- ! [[Hyperlipoproteinemia type Ic/ja|c]] | {{OMIM|118830||none}} | | 血中の[[Lipoprotein lipase/ja|LPL]]阻害 |- !rowspan=2| II型 ! a | {{OMIM|143890||none}} | [[Familial hypercholesterolemia/ja]] | [[LDL receptor/ja]]欠乏症 | [[LDL/ja]] | [[Xanthelasma/ja]], [[arcus senilis/ja]], 腱黄色腫 | [[Bile acid sequestrant/ja]], [[statin/ja]], [[niacin (substance)/ja|ナイアシン]] | クリア | ヘテロ接合体は500人に1人 |- ! b | {{OMIM|144250||none}} | 家族性複合高脂血症 | [[LDL receptor/ja]]の減少と[[apolipoprotein B/ja|ApoB]]の増加 | [[LDL/ja]]と[[VLDL/ja]] | | スタチン, ナイアシン, [[fibrate/ja]] | 濁っている | 100人に1人 |- !colspan=2| III型 | {{OMIM|107741||none}} | [[Familial dysbetalipoproteinemia/ja]] | [[apolipoprotein E/je|Apo E 2]]合成の欠陥 | [[Intermediate density lipoprotein/ja|IDL]] | 結節性黄色腫および手掌黄色腫 | フィブラート, スタチン | 濁っている | 1万人に1人 |- !colspan=2| IV型 | {{OMIM|144600||none}} | [[Familial hypertriglyceridemia/ja]] | VLDLの産生が増加し、排泄が減少する。 | VLDL | トリグリセリド値が高いと[[pancreatitis/ja|膵炎]]を引き起こす可能性がある。 | フィブラート, ナイアシン, スタチン | 濁っている | 100人に1人 |- !colspan=2| [[#type V|V型]] | {{OMIM|144650||none}} | | VLDL産生が増加し、[[Lipoprotein lipase/ja|LDL]]が減少する。 | VLDLとカイロミクロン | | ナイアシン, フィブラート | 上層はクリーミーで、下層は濁っている。 | |} |